Inhibitor Therapy
SciencePress Release2023-03-23 11:30:00
BBP-398, an investigational SHP2 inhibitor, is a potentially best-in-class therapy for use in combination approaches, which is shown by preclinical findings...
HealthPress Release2023-03-23 12:39:00
Researchers have unraveled key physiological mechanisms to pave the way for the discovery of novel therapeutics XI'AN, China, March 23, 2023...
HealthPress Release2023-03-23 10:11:00
CAMBRIDGE, Mass., March 23, 2023 /PRNewswire/ -- ONO PHARMA USA, INC., announced that its candidate, tirabrutinib (ONO-4059), a Bruton's tyrosine kinase...
SciencePress Release2023-03-23 20:01:00
Phase 2 trials of VTX958 (TYK2 inhibitor) are ongoing in plaque psoriasis, Crohns disease and psoriatic arthritis, with topline Phase 2 data in plaque...
SciencePress Release2023-03-23 11:00:00
Validive Phase 2b/3 VOICE Trial Anticipates Go/No-Go Interim Readout by End of Next Week Camsirubicin Phase 1b Dose-Escalation Trial Now Enrolling 5th...
SciencePress Release2023-03-23 12:00:00
Media Release 2 nd line NSCLC patients refractory to anti-PD-(L)1 treatment have few therapeutic options, and the addition of efti to pembrolizumab may help...
HealthPress Release2023-03-23 10:30:00
CAMBRIDGE, Mass., March 23, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely...
SciencePress Release2023-03-23 10:30:00
Progress in Three Phase 3 Trials in Areas of High Unmet Clinical Need, Including Positive Sorbitol Reduction Data from the Ongoing Phase 3 INSPIRE Trial in...
Business / FinanceBy Rtt News2023-03-23 02:25:23
(RTTNews) - Incyte (INCY) said that the U.S. Food and Drug Administration has approved Zynyz (retifanlimab-dlwr) for the treatment of adults with metastatic...
SciencePress Release2023-03-22 21:23:00
REZZAYO is a novel, once-weekly, next-generation echinocandin indicated for the treatment of candidemia and invasive candidiasis in adults with limited or no...
Business / FinanceBy Vandana Singh2023-03-23 14:35:33
The FDA approved Cidara Therapeutics Inc's CDTX antifungal Rezzayo (rezafungin) under priority review for treating candidemia and invasive candidiasis in...
Business / FinancePress Release2023-03-23 14:59:58
Drugs For Hormonal Replacement Therapy Global Market Report 2023 - Market Size, Trends, And Global Forecast 2023-2032 The Business Research Company's Drugs...
HealthPress Release2023-03-23 13:00:00
Results of the M19-130 (SLEek) Phase 2 trial of upadacitinib given alone or as a combination therapy (ABBV-599) met the primary endpoint of systemic lupus...
SciencePress Release2023-03-23 13:00:00
ORION CORPORATION PRESS RELEASE 23 March 2023 at 15:00 EET Orion and Bayer expand clinical development program for darolutamide in prostate cancer Phase III...
HealthBy Annika Kim Constantino2023-03-22 22:55:25
Key Points The FDA's independent panel of advisors voted against the effectiveness of Biogen's investigational ALS drug for a rare and aggressive form of the...
SciencePress Release2023-03-23 17:23:00
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of targeted therapies...
Business / FinanceBy Business Wire2023-03-23 06:00:00
Sanofi collaboration for Natural Killer cell engager therapeutics expanded to B7-H3 ANKET program and two additional targets, with 25 million payment...
HealthBy Annika Kim Constantino2023-03-23 18:31:20
Key Points Shares of drugmakers Sanofi and Regeneron both jumped more than 6% on Thursday after they released data on a jointly developed drug that shows...
Business / FinanceBy Pr Newswire2023-03-22 23:30:00
Presentations Explore ARIA with the Use of Antiplatelets or Anticoagulants and Isolated ARIA-H in Patients from Eisai's Lecanemab Phase 3 Confirmatory...
SciencePress Release2023-03-23 11:55:00
Evaxions AI technology has led to the identification of new viral targets for cancer immunotherapy This potentially enables treatment for patients with cold...